Loading

Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.46439/signaling.3.061

A new role of dopamine receptor D2 agonist ropinirole: Targeting NAT10 for treating periodontitis

  • 1Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction & College and Hospital of Stomatology, Guangxi Medical University, Nanning 530021, China
+ Affiliations - Affiliations

Corresponding Author

Lufei Wang, wlfdentist@outlook.com

Received Date: December 19, 2024

Accepted Date: February 11, 2025

Keywords

Ac4C, NAT10, KLF6, Ropinirole, Periodontitis, Alveolar bone loss, Inflammatory.

Author Information X